Researchers have a new hope for preventing severe illness from the bird flu after finding a groundbreaking antibody treatment ...

A prophylactic antibody-based immune therapy protects monkeys against severe disease caused by H5N1 avian flu, University of Pittsburgh and NIH Vaccine Research Center researchers report in Science.

A new antibody therapy effectively protects monkeys from severe H5N1 avian flu, offering hope for a universal flu vaccine and ...

The antibody targets a stable part of the bird flu virus, ensuring that the immune protection can resist new variants and offer long-term protection against the globally spreading airborne infection.

Nearly 200 rhesus macaque monkeys live in and roam Florida’s Silver Spring State Park, where they were first introduced ...

Because seasonal flu viruses change and avoid immune responses built up in prior years ... circumvents the abovementioned challenge and provides broadly neutralizing protection. In a new study, ...

The antibodies target a stable part of the bird flu virus, ensuring that the immune protection can resist new variants and ...

A prophylactic antibody-based immune therapy protects monkeys against severe disease caused by H5N1 avian flu, University of Pittsburgh and NIH Vaccine Research Center researchers report in Science.

Researchers at the University of Pittsburgh have taken a step toward developing a bird flu vaccine. And their findings could ...

Scientists found that a moderate dose of MEDI8852, an antibody therapy, effectively protected monkeys against severe H5N1 avian flu.